Repeated arsenic trioxide intravenous infusion causes focal bone marrow necrosis in two acute promyelocytic leukemia patients

MeSH terms

• Adult
• Antineoplastic Agents / adverse effects*
• Arsenic Trioxide
• Arsenicals / adverse effects*
• Bone Marrow / pathology*
• Bone Marrow Diseases / chemically induced*
• Child
• Female
• Humans
• Infusions, Intravenous
• Leukemia, Promyelocytic, Acute / drug therapy*
• Male
• Necrosis
• Oxides / adverse effects*